Active Startup: Laurent Pharma

Published: 10 October 2019

Business Snapshot
Company has developed a clinical stage, orally-active drug candidate with the potential to modulate the immuno-inflammatory response in cystic fibrosis patients.

Target Markets
Cystic fibrosis

Intellectual Property
Patents around the world

Danuta Radzioch, Radu Pislariu

Back to top